Clinical Trial Update: Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301) [Phase 3]

View source ↗

Summary

This is an extension/update to a Phase 3 long-term study evaluating valsartan and amlodipine in patients with essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED